<DOC>
	<DOCNO>NCT02438397</DOCNO>
	<brief_summary>study objective : explore efficacy acarbose metformin glucose fluctuation add therapy type 2 diabetes patient inadequately control premix insulin .</brief_summary>
	<brief_title>Efficacy Acarbose Metformin Blood Glucose Fluctuation When Combined With Premix Insulin</brief_title>
	<detailed_description>Study Design : Prospective , parallel group , active-control , randomize , open-label . Study Organization : Single-center China . Endocrinology metabolism department 6th affiliated hospital Shanghai Jiaotong university Study Population : Type 2 diabetes inadequately control premix-insulin therapy,40 patient per arm ( acarbose add on/ metformin add ) acarbose metformin widely use premix-insulin clinical practice , good glucose control lower hypoglycemia incident . Acarbose delay absorption digest carbohydrate small intestine thus low postprandial glucose insulin level sequently improve glucose fluctuation Metformin improve insulin resistance reduce gluconeogenesis , glucose output thus low fasting glucose</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Diagnosed T2DM patient ( WHO , 1999 ) . Premix Insulin therapy 3 month , daily dosage insulin &gt; 20IU &lt; 1IU/kg 30 ≤Age ≤ 70 year old , male female 7.0 ≤ HbA1c ≤10.0 % 18.5≤ BMI ≤ 35 kg/m2 Written Informed consent Subject type 1 diabetes gestational diabetes mellitus specific type DM Those tolerate AGI suffer GI disease Metformin contradiction Concomitant 2 oral antidiabetes medicine , 1 OAD maximum dose Subject repeat severe hypoglycemia and/or unawareness hypoglycemia Known suspect allergy trial product ( ) relate product Females child bear potential pregnant , breastfeed intention become pregnant use adequate contraceptive method throughout trial Impaired liver function , Any clinically significant condition major systemic disease , include serious coronary heart disease , cardiovascular disease , cancer , TB , acute infection Uncontrolled hypertension Concomitant treatment influence blood glucose Impaired renal function</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>